Literature DB >> 24825477

Electrophysiological profile of the patients with MuSK positive myasthenia gravis.

Ana Nikolic, Ivana Basta, Vidosava Rakocevic Stojanovic, Zorica Stevic, Dragana Lavrnic.   

Abstract

OBJECTIVES: To determine the electrophysiological profile of our cohort of patients with muscle-specific tyrosine kinase (MuSK) positive myasthenia gravis (MG).
METHODS: Repetitive nerve stimulation test (RNS) and jitter analysis using concentric needle electrode were performed in 31 MuSK and in 28 acetylcholine receptor (AChR) positive MG patients.
RESULTS: Pathological RNS was verified in 16 (51.6%) MuSK and 26 (92.9%) AChR MG patients (P < 0.01). Pathological jitter analysis was registered in 28 (90.3%) MuSK and 26 (92.9%) AChR MG patients (P > 0.05). Increased jitter was present in extensor digitorum communis (EDC) in 23 (74.2%) MuSK and in 25 (89.3%) AChR MG patients (P > 0.05) as well as in orbicularis oculi (OO) muscle in 24 (85.7%) MuSK and 22 (81.5%) AChR MG patients (P > 0.05). Lower mean value of mean consecutive difference (MCD) and fewer potential pairs with increased jitter were registered in MuSK MG compared to AChR MG patients only in EDC muscle (P < 0.05). In MuSK MG patients, increased jitter was observed to be more frequent in patients with longer disease duration (P < 0.05) and also in those patients exhibiting more severe disease forms (P < 0.01) only in EDC muscle. DISCUSSION: Repetitive nerve stimulation test has low sensitivity in MuSK MG patients, while jitter analysis shows high sensitivity, especially in facial muscles. The EDC muscle in MuSK MG patients usually shows increased jitter in more severe disease forms and later in the course of the disease.

Entities:  

Keywords:  EMG,; MuSK,; Myasthenia gravis,; Neurophysiology

Mesh:

Substances:

Year:  2014        PMID: 24825477     DOI: 10.1179/1743132814Y.0000000387

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  3 in total

Review 1.  Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.

Authors:  Michael H Rivner; Mamatha Pasnoor; Mazen M Dimachkie; Richard J Barohn; Lin Mei
Journal:  Neurol Clin       Date:  2018-05       Impact factor: 3.806

Review 2.  Bedside and laboratory diagnostic testing in myasthenia.

Authors:  Katie Yoganathan; Alexander Stevenson; Awais Tahir; Ross Sadler; Aleksandar Radunovic; Naveed Malek
Journal:  J Neurol       Date:  2022-02-10       Impact factor: 6.682

3.  Repetitive Nerve Stimulation in MuSK-Antibody-Positive Myasthenia Gravis.

Authors:  Seung Woo Kim; Mun Kyung Sunwoo; Seung Min Kim; Ha Young Shin; Il Nam Sunwoo
Journal:  J Clin Neurol       Date:  2017-05-15       Impact factor: 3.077

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.